Neutral
AI recommendation signal analysis across 307 domains for the Neutral persona in Weight Loss Clinics GLP-1 Telehealth.
Many tables and charts on this page show only the top few results; the full data behind them runs far deeper. The complete report unlocks every row, chart, and download for this industry.
Get the full Weight Loss Clinics GLP-1 Telehealth report →How to use this page
Cite data, then create it
The reports and statistics ranking for this industry. Use them as sources worth citing, and as a gap analysis for original research worth publishing: data is what earns links and citations.
Where the numbers come from
We run reports, stats, research queries for this industry through Google and aggregate every result: domains by rank-weighted score (higher positions count for more) and appearance count, exact URLs by appearance count, and the most common title phrases.
What's on this page
Domain and URL charts, the full result list, and title n-gram tables.
Research: Reports, Stats, Research
Domains appearing in Google results for Neutral's Research: Reports, Stats, Research queries. Score is a rank-weighted sum (higher-ranked appearances count for more); count is a plain appearance tally.
Top URLs
Individual pages (not just domains) ranked by the same rank-weighted score, labeled by page title.
All Results
Every result for Neutral's Research: Reports, Stats, Research queries, ranked by how many times each exact URL appeared (ties broken by average rank position, so appearing higher up wins), a different aggregation than the score-based charts above. Title and URL links open in a new tab.
Title N-Grams
Most common word phrases (2 to 7 words) across every result title for these queries.
2-grams
| 135 | glp 1 |
| 55 | weight loss |
| 25 | of glp |
| 19 | 1 weight |
| 19 | 1 receptor |
| 17 | 1 drugs |
| 15 | glucagon like |
| 14 | like peptide |
| 14 | 1 agonists |
| 13 | trends in |
| 13 | glp 1s |
| 12 | loss drugs |
| 12 | peptide 1 |
| 12 | receptor agonists |
| 10 | for weight |
| 10 | real world |
| 10 | 1 ra |
| 9 | agonists and |
| 8 | in the |
| 7 | in glp |
| 7 | loss drug |
| 7 | 1 medications |
| 5 | in glucagon |
| 5 | receptor agonist |
| 5 | about glp |
3-grams
| 23 | of glp 1 |
| 19 | glp 1 weight |
| 17 | 1 weight loss |
| 17 | glp 1 drugs |
| 14 | glucagon like peptide |
| 12 | weight loss drugs |
| 12 | like peptide 1 |
| 12 | glp 1 agonists |
| 12 | 1 receptor agonists |
| 11 | glp 1 receptor |
| 10 | for weight loss |
| 10 | glp 1 ra |
| 8 | peptide 1 receptor |
| 7 | in glp 1 |
| 7 | weight loss drug |
| 7 | glp 1 medications |
| 7 | 1 agonists and |
| 6 | trends in glp |
| 5 | in glucagon like |
| 5 | 1 receptor agonist |
| 4 | a glp 1 |
| 4 | trends in glucagon |
| 4 | glp 1 trends |
| 4 | glp 1 drug |
| 4 | the glp 1 |
4-grams
| 17 | glp 1 weight loss |
| 12 | glucagon like peptide 1 |
| 10 | glp 1 receptor agonists |
| 8 | like peptide 1 receptor |
| 6 | trends in glp 1 |
| 6 | glp 1 agonists and |
| 5 | in glucagon like peptide |
| 5 | peptide 1 receptor agonist |
| 5 | of glp 1 receptor |
| 4 | 1 weight loss drugs |
| 4 | trends in glucagon like |
| 4 | of glp 1 drugs |
| 4 | rise of glp 1 |
| 4 | of glp 1 weight |
| 4 | glp 1 ra prescribing |
| 4 | 1 ra prescribing trends |
| 4 | 1 receptor agonists for |
| 3 | the rise of glp |
| 3 | 1 weight loss drug |
| 2 | drugs for weight loss |
| 2 | used a glp 1 |
| 2 | a glp 1 drug |
| 2 | real world trends in |
| 2 | world trends in glp |
| 2 | in glp 1 treatment |
5-grams
| 8 | glucagon like peptide 1 receptor |
| 5 | in glucagon like peptide 1 |
| 5 | like peptide 1 receptor agonist |
| 5 | of glp 1 receptor agonists |
| 4 | glp 1 weight loss drugs |
| 4 | trends in glucagon like peptide |
| 4 | of glp 1 weight loss |
| 4 | glp 1 ra prescribing trends |
| 3 | the rise of glp 1 |
| 3 | rise of glp 1 weight |
| 3 | glp 1 weight loss drug |
| 3 | glp 1 receptor agonists for |
| 2 | used a glp 1 drug |
| 2 | real world trends in glp |
| 2 | world trends in glp 1 |
| 2 | trends in glp 1 treatment |
| 2 | in glp 1 treatment persistence |
| 2 | glp 1 treatment persistence and |
| 2 | glp 1 prescriptions for weight |
| 2 | 1 prescriptions for weight loss |
| 2 | glp 1s for weight loss |
| 2 | peptide 1 receptor agonist use |
| 2 | of americans have used glp |
| 2 | americans have used glp 1 |
| 2 | have used glp 1 weight |
6-grams
| 5 | glucagon like peptide 1 receptor agonist |
| 4 | trends in glucagon like peptide 1 |
| 4 | in glucagon like peptide 1 receptor |
| 3 | rise of glp 1 weight loss |
| 3 | of glp 1 receptor agonists for |
| 2 | real world trends in glp 1 |
| 2 | world trends in glp 1 treatment |
| 2 | trends in glp 1 treatment persistence |
| 2 | in glp 1 treatment persistence and |
| 2 | glp 1 prescriptions for weight loss |
| 2 | like peptide 1 receptor agonist use |
| 2 | of americans have used glp 1 |
| 2 | americans have used glp 1 weight |
| 2 | the popularity of glp 1 drugs |
| 2 | popularity of glp 1 drugs has |
| 2 | glp 1 drugs linked to lower |
| 2 | glp 1 agonists us sees 700 |
| 2 | 1 agonists us sees 700 increase |
| 2 | agonists us sees 700 increase over |
| 2 | us sees 700 increase over four |
| 2 | sees 700 increase over four years |
| 2 | 700 increase over four years in |
| 2 | how the rise of glp 1 |
| 2 | the rise of glp 1 weight |
| 2 | of glp 1 weight loss drug |
7-grams
| 4 | trends in glucagon like peptide 1 receptor |
| 4 | in glucagon like peptide 1 receptor agonist |
| 2 | real world trends in glp 1 treatment |
| 2 | world trends in glp 1 treatment persistence |
| 2 | trends in glp 1 treatment persistence and |
| 2 | glucagon like peptide 1 receptor agonist use |
| 2 | of americans have used glp 1 weight |
| 2 | the popularity of glp 1 drugs has |
| 2 | glp 1 agonists us sees 700 increase |
| 2 | 1 agonists us sees 700 increase over |
| 2 | agonists us sees 700 increase over four |
| 2 | us sees 700 increase over four years |
| 2 | sees 700 increase over four years in |
| 2 | how the rise of glp 1 weight |
| 2 | the rise of glp 1 weight loss |
| 2 | rise of glp 1 weight loss drug |
| 2 | of glp 1 weight loss drug could |
| 2 | glp 1 weight loss drug could boost |
| 2 | 1 weight loss drug could boost the |
| 2 | weight loss drug could boost the u |
| 2 | loss drug could boost the u s |
| 2 | glp 1 research to explore weight loss |
| 2 | 1 research to explore weight loss drug |
| 2 | research to explore weight loss drug consumer |
| 2 | to explore weight loss drug consumer trends |